Showing results (461-470 of 502) with videos related to

Sort By:
Pageof 51
JCI Insight|March 15, 2017
Targeting adhesion signaling in <i>KRAS, LKB1</i> mutant lung adenocarcinomaMelissa Gilbert-Ross, Jessica Konen, Junghui Koo, et al.
The New England Journal of Medicine|April 17, 2018
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational BurdenMatthew D Hellmann, Tudor-Eliade Ciuleanu, Adam Pluzanski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2020
A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid TumorsTaofeek K Owonikoko, R Donald Harvey, Bradley Carthon, et al.
Journal for Immunotherapy of Cancer|September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
The New England Journal of Medicine|June 3, 2024
Osimertinib after Chemoradiotherapy in Stage III <i>EGFR</i>-Mutated NSCLCShun Lu, Terufumi Kato, Xiaorong Dong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2022
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227Julie R Brahmer, Jong-Seok Lee, Tudor-Eliade Ciuleanu, et al.
Cancer|October 18, 2018
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapyMehmet A Bilen, Dylan J Martini, Yuan Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2014
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014Daniel Morgensztern, Meghan J Campo, Suzanne E Dahlberg, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesisChang-Soo Seong, Chunzi Huang, Austin C Boese, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2020
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung CancerMatthew P Smeltzer, Murry W Wynes, Sylvie Lantuejoul, et al.
Pageof 51